A1CF | APOBEC1 complementation factor | Predicted intracellular proteins
| | | | | Tissue enhanced |
AADAC | Arylacetamide deacetylase | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ABCA4 | ATP-binding cassette, sub-family A (ABC1), member 4 | Disease related genes Plasma proteins Potential drug targets Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCB1 | ATP-binding cassette, sub-family B (MDR/TAP), member 1 | Cancer-related genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted intracellular proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ABCG2 | ATP-binding cassette, sub-family G (WHITE), member 2 (Junior blood group) | Cancer-related genes CD markers Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ACE2 | Angiotensin I converting enzyme 2 | Enzymes FDA approved drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
ADAMDEC1 | ADAM-like, decysin 1 | Enzymes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ADTRP | Androgen-dependent TFPI-regulating protein | Predicted membrane proteins
| | | | | Tissue enhanced |
AGR3 | Anterior gradient 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AKR1B10 | Aldo-keto reductase family 1, member B10 (aldose reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
AKR7A3 | Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase) | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANKS4B | Ankyrin repeat and sterile alpha motif domain containing 4B | Predicted intracellular proteins
| | | | | Tissue enhanced |
ANO9 | Anoctamin 9 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ANXA13 | Annexin A13 | Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
AQP11 | Aquaporin 11 | Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
B3GALT5 | UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
B3GNT8 | UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 8 | Predicted secreted proteins
| | | | | Tissue enhanced |
BAIAP2L2 | BAI1-associated protein 2-like 2 | Predicted intracellular proteins
| | | | | Tissue enhanced |
BCO1 | Beta-carotene oxygenase 1 | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
BRINP3 | Bone morphogenetic protein/retinoic acid inducible neural-specific 3 | Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BTNL2 | Butyrophilin-like 2 (MHC class II associated) | Disease related genes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
C1orf106 | Chromosome 1 open reading frame 106 | Predicted intracellular proteins
| | | | | Tissue enhanced |
C6orf222 | Chromosome 6 open reading frame 222 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CA13 | Carbonic anhydrase XIII | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
CALML4 | Calmodulin-like 4 | Predicted intracellular proteins
| | | | | Tissue enhanced |
CBLC | Cbl proto-oncogene C, E3 ubiquitin protein ligase | Cancer-related genes Predicted intracellular proteins
| | | | | Tissue enhanced |
CCL15 | Chemokine (C-C motif) ligand 15 | Plasma proteins Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CCL24 | Chemokine (C-C motif) ligand 24 | Predicted secreted proteins
| | | | | Tissue enhanced |
CDHR5 | Cadherin-related family member 5 | Plasma proteins Predicted intracellular proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CLDN3 | Claudin 3 | Cancer-related genes Disease related genes Predicted membrane proteins
| | | | | Tissue enhanced |
CLEC4F | C-type lectin domain family 4, member F | Predicted membrane proteins
| | | | | Tissue enhanced |
CYP2C18 | Cytochrome P450, family 2, subfamily C, polypeptide 18 | Enzymes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
CYP2J2 | Cytochrome P450, family 2, subfamily J, polypeptide 2 | Enzymes Predicted secreted proteins
| | | | | Tissue enhanced |
CYP3A5 | Cytochrome P450, family 3, subfamily A, polypeptide 5 | Cancer-related genes Enzymes Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CYP4F12 | Cytochrome P450, family 4, subfamily F, polypeptide 12 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DAB1 | Dab, reelin signal transducer, homolog 1 (Drosophila) | Predicted intracellular proteins
| | | | | Tissue enhanced |
DDC | Dopa decarboxylase (aromatic L-amino acid decarboxylase) | Disease related genes Enzymes FDA approved drug targets Predicted intracellular proteins
| | | | | Tissue enhanced |
DEGS2 | Delta(4)-desaturase, sphingolipid 2 | Predicted intracellular proteins Predicted membrane proteins
| | | | | Tissue enhanced |
DHDH | Dihydrodiol dehydrogenase (dimeric) | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
DNASE1 | Deoxyribonuclease I | Disease related genes Enzymes Potential drug targets Predicted intracellular proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DPEP1 | Dipeptidase 1 (renal) | Enzymes FDA approved drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
DPP4 | Dipeptidyl-peptidase 4 | CD markers Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
DQX1 | DEAQ box RNA-dependent ATPase 1 | Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
EDN2 | Endothelin 2 | Predicted secreted proteins
| | | | | Tissue enhanced |
EDN3 | Endothelin 3 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
ENPEP | Glutamyl aminopeptidase (aminopeptidase A) | CD markers Enzymes Plasma proteins Predicted intracellular proteins
| | | | | Tissue enhanced |
ENPP3 | Ectonucleotide pyrophosphatase/phosphodiesterase 3 | CD markers Enzymes Predicted intracellular proteins
| | | | | Tissue enhanced |
ENTPD8 | Ectonucleoside triphosphate diphosphohydrolase 8 | Enzymes Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
EPCAM | Epithelial cell adhesion molecule | Cancer-related genes CD markers Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |